Researchers have analysed the therapeutic benefits of an antiviral drug, nirmatrelvir, and a class of drugs typically used for bone disorders, bisphosphonates, on the coronavirus. Nirmatrelvir treatment proved effective in preventing severe disease but might impact the host immune system’s ability to combat the virus in future. Meanwhile, bisphosphonates were found to enhance antibody responses to viral antigens, reducing COVID-19 risk and hospitalisation rates.
Critical Claude Code Flaw Silently Bypasses Developer-Configured Security Rules
A high-severity security bypass vulnerability in Anthropic’s Claude Code AI coding agent allows malicious actors to silently evade user-configured deny rules through a simple command-padding
